MedPath

OPTIMYXIN PLUS

OPTIMYXIN PLUS

Discontinued
DIN Number

00807435

Drug Class

Human

Market Date

Dec 31, 1989

Company
HC

euro-pharm international canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00807435
AIG Number0331392001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S03AA30 ANTIINFECTIVES, COMBINATIONS
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic ,  Otic
AHFS Classification52:04.04
Health Canada Classification

ACTIVE INGREDIENTS (3)

GRAMICIDINActive
Strength: 0.025 MG / ML
Monograph: GRAMICIDIN
NEOMYCIN (NEOMYCIN SULFATE)Active
Strength: 1.75 MG / ML
Monograph: NEOMYCIN (NEOMYCIN SULFATE)
POLYMYXIN B (POLYMYXIN B SULFATE)Active
Strength: 10000 UNIT / ML
Monograph: POLYMYXIN B (POLYMYXIN B SULFATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.